Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sapio Sciences Announces Exemplar NGS LIMS for Next Gen Sequencing Labs

Published: Monday, January 27, 2014
Last Updated: Sunday, January 26, 2014
Bookmark and Share
Exemplar NGS provides pre-built, clinical standard workflows for leading NGS platforms

Sapio Sciences has announce the release of Exemplar NGS LIMS. Sapio’s NGS LIMS system will track multiple next-generation sequencing (NGS) platform workflows from request through processing and analysis.

Sapio has gained extensive expertise over 5+ years of working with prominent NGS labs resulting in the industry’s leading solution for this important and rapidly growing market segment. Exemplar’s NGS LIMS features all of the following:
- Pre-built, CLIA standard, workflows for leading NGS platforms
- Instrument integrations with NGS platforms and leading QC instruments
- Support for automation via integration with leading robotic sample preparation platforms
- Highly graphical and intuitive interface
- Graphical executive dashboard for viewing of lab activity in any timeframe
- Complete consumables management for reagents and other consumables with re-order alerts
- 100% web based solution with no extra software required on the client
- Tablet enabled for usage on iPads and other tablets
- Scalable from small labs to large, multi-national, multi-lab deployments

“We are honored to have a who’s who of customers in the NGS market for both clinical and research applications. Critical to our success in this market has been our deep knowledge of this domain, but more importantly it’s the result of the high level of flexibility of the Exemplar platform.” said Kevin Cramer, VP at Sapio Sciences. “We have learned that even when NGS clients are using the same platforms, they have very diverse requirements in data organization, process flow and library preparations and Exemplar is the only solution that enables rapid support for each client’s specific needs.”

Exemplar NGS LIMS is targeted at NGS labs, but retains the full capability of the Exemplar ecosystem to address any lab’s needs. The result is that diverse lab requirements not limited to NGS such as genotyping, proteomics, etc. can all be supported via Exemplar.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Exemplar LIMS Accelerates Mitomics CLIA Certification and Serves as Foundation of Operations
Phase One of the project encompassed a large scope
Tuesday, November 29, 2011
Scientific News
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!